Study CHAMPIONs cangrelor antiplatelet
The fast-acting antiplatelet agent cangrelor significantly reduces the risk for ischemic events, including stent thrombosis, in patients during percutaneous coronary intervention, without significantly increasing severe bleeding, researchers report.
Source: MedWire News - Cardiology - Category: Cardiology Source Type: news
More News: Angioplasty | Bleeding | Cardiology | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Study | Thrombosis